Epsilon M&A Deal Report - Synergy Health
Transaction Multiples for the Valuation of Private Companies
Steris / Synergy Health
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratories
EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
---|---|---|---|---|---|---|---|---|
Historic | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
Current | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Multiple available |
n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratories » = 130
Date | Acquirer | Target | Country | Multiples | See details |
29/07/2015 | Biogroup SELAS (LBM CAB) | Laboratoires LCD | France | * | 75077 |
20/11/2015 | SurModics | Creagh Medical | Ireland | * | 75005 |
Source: Epsilon Research / EMAT